Stay updated on Nivolumab & Ibrutinib in CNS Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab & Ibrutinib in CNS Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab & Ibrutinib in CNS Lymphoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. No visible changes to study content or navigation.
    Difference
    0.1%
    Check dated 2026-03-10T14:48:38.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    A small revision update from v3.4.1 to v3.4.2 is shown; study content and user-facing information appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-17T03:07:35.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added and the older notices (including the lapse in government funding message and Revision: v3.4.0) were removed; these are footer/system updates and do not affect the study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-09T22:47:04.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding was added, indicating the information may not be up to date and the NIH Clinical Center is open, with links to cc.nih.gov and opm.gov for more details.
    Difference
    0.4%
    Check dated 2026-02-02T20:31:59.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    UI changes include adding a 'Show glossary' option and new metadata lines 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0', while removing the previous lines 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-26T19:34:23.000Z thumbnail image
  8. Check
    57 days ago
    Change Detected
    Summary
    The page shows a minor revision update: added Revision: v3.3.4 and removed Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-19T14:22:24.000Z thumbnail image

Stay in the know with updates to Nivolumab & Ibrutinib in CNS Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab & Ibrutinib in CNS Lymphoma Clinical Trial page.